{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:24:34Z","timestamp":1787009074890,"version":"build-2736575974"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"name":"SNA International"},{"name":"SNA International"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A safe and productive workplace requires a sober workforce, free from substances that impair judgment and concentration. Although drug monitoring programs already exist, the scope and loopholes of standard workplace testing panels are well known, allowing other substances to remain a source of risk. Therefore, a high-throughput urine screening method for psilocin, mitragynine, phencyclidine, ketamine, norketamine and dehydronorketamine was developed and validated in conjunction with a urine and blood confirmation method. There are analytical challenges to overcome with psilocin and mitragynine, particularly when it comes to drug stability and unambiguous identification in authentic specimens. Screening and confirmation methods were validated according to the American National Standards Institute\/Academy Standards Board (ANSI\/ASB) Standard 036, Standard Practices for Method Validation in Forensic Toxicology. An automated liquid handling system equipped with dispersive pipette extraction tips was utilized for preparing screening samples, whereas an offline solid-phase extraction method was used for confirmation sample preparation. Both methods utilized liquid chromatography-tandem mass spectrometry to achieve limits of detection between 1\u20135\u2009ng\/mL for the screening method and 1\u2009ng\/mL for the confirmation method. Automation allows for faster throughput and enhanced quality assurance, which improves turnaround time. Compared to previous in-house methods, specimen volumes were substantially decreased for both blood and urine, which is an advantage when volume is limited. This screening technique is well suited for evaluating large numbers of specimens from those employed in safety-sensitive workforce positions. This method can be utilized by workplace drug testing, human performance and postmortem laboratories seeking robust qualitative screening and confirmation methods for analytes that have traditionally been challenging to routinely analyze.<\/jats:p>","DOI":"10.1093\/jat\/bkae002","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T15:45:23Z","timestamp":1705938323000},"page":"111-118","source":"Crossref","is-referenced-by-count":5,"title":["Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography\u2013tandem mass spectrometry"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0865-1277","authenticated-orcid":false,"given":"Madeleine E","family":"Wood","sequence":"first","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenna J","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin L","family":"Karschner","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua Z","family":"Seither","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan T","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L","family":"Knittel","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4228-7276","authenticated-orcid":false,"given":"Jeffrey P","family":"Walterscheid","sequence":"additional","affiliation":[{"name":"Division of Forensic Toxicology, Armed Forces Medical Examiner System , 115 Purple Heart Dr., Dover AFB, DE 19902, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"2024030117230329600_R1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"key":"2024030117230329600_R2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.euroneuro.2020.02.001","article-title":"A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding","volume":"33","author":"Madsen","year":"2020","journal-title":"European Neuropsychopharmacology"},{"key":"2024030117230329600_R3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.111.103309","article-title":"Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin","volume":"200","author":"Carhart-Harris","year":"2012","journal-title":"British Journal of Psychiatry"},{"key":"2024030117230329600_R4","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/0269881119857204","article-title":"Microdosing psychedelics: more questions than answers? An overview and suggestions for future research","volume":"33","author":"Kuypers","year":"2019","journal-title":"Journal of Psychopharmacology"},{"key":"2024030117230329600_R5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acsptsci.0c00176","article-title":"Investigation of the structure-activity relationships of psilocybin analogues","volume":"4","author":"Klein","year":"2021","journal-title":"ACS Pharmacology & Translational Science"},{"key":"2024030117230329600_R6","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1016\/j.bmcl.2005.06.104","article-title":"SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonist","volume":"15","author":"Sard","year":"2005","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"2024030117230329600_R7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0379-0738(00)00213-9","article-title":"Detection of psilocin in body fluids","volume":"113","author":"Sticht","year":"2000","journal-title":"Forensic Science International"},{"key":"2024030117230329600_R8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jat\/30.5.342","article-title":"Psilocin identified in a DUID investigation","volume":"30","author":"Tiscione","year":"2006","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jchromb.2003.08.030","article-title":"Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples","volume":"796","author":"Kamata","year":"2003","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"2024030117230329600_R10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00414-012-0796-1","article-title":"Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS\/MS","volume":"127","author":"Martin","year":"2013","journal-title":"International Journal of Legal Medicine"},{"key":"2024030117230329600_R11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00414-011-0652-8","article-title":"A validated method for quantitation of psilocin in plasma by LC-MS\/MS and study of stability","volume":"126","author":"Martin","year":"2012","journal-title":"International Journal of Legal Medicine"},{"key":"2024030117230329600_R12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Testing and Analysis"},{"key":"2024030117230329600_R13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jat\/31.8.497","article-title":"Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine","volume":"31","author":"Del Mar Ramirez Fernandez","year":"2007","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1355-0306(06)71579-9","article-title":"Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography","volume":"46","author":"Anastos","year":"2006","journal-title":"Science and Justice"},{"key":"2024030117230329600_R15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2014.01.006","article-title":"Synthesis, hydrolysis and stability of psilocin glucuronide","volume":"237","author":"Martin","year":"2014","journal-title":"Forensic Science International"},{"key":"2024030117230329600_R16","first-page":"9","article-title":"Phencyclidine intoxication and adverse effects: a clinical and pharmacological review of an illicit drug","volume":"8","author":"Bey","year":"2007","journal-title":"California Journal of Emergency Medicine"},{"key":"2024030117230329600_R17","first-page":"1","article-title":"Emergency department visits involving phencyclidine (PCP)","volume-title":"The CBHSQ Report, Rockville (MD)","author":"Bush","year":"2013"},{"key":"2024030117230329600_R18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1081\/CLT-120026525","article-title":"Massive venlafaxine overdose resulted in a false positive Abbott AxSYM urine immunoassay for phencyclidine","volume":"41","author":"Bond","year":"2003","journal-title":"Journal of Toxicology Clinical Toxicology"},{"key":"2024030117230329600_R19","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1080\/15563650.2018.1483026","article-title":"False-positive phencyclidine immunoassay results caused by metronidazole","volume":"56","author":"Fernandez","year":"2018","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"2024030117230329600_R20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/dta.1371","article-title":"False-positive phencyclidine immunoassay results caused by 3,4-methylenedioxypyrovalerone (MDPV)","volume":"5","author":"Macher","year":"2013","journal-title":"Drug Testing and Analysis"},{"key":"2024030117230329600_R21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/15563650.2013.801982","article-title":"How often do false-positive phencyclidine urine screens occur with use of common medications?","volume":"51","author":"Rengarajan","year":"2013","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"2024030117230329600_R22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/jat\/33.9.569","article-title":"Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry","volume":"33","author":"Fritch","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R23","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/anatox\/35.7.481","article-title":"Evaluation of a new phencyclidine enzyme immunoassay for the detection of phencyclidine in urine with confirmation by high-performance liquid chromatography-tandem mass spectrometry","volume":"35","author":"Poklis","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R24","first-page":"77","article-title":"Reviewing the physiology, pharmacology and therapeutic uses of ketamine","volume":"36","author":"Hunt","year":"2021","journal-title":"Nursing Standard"},{"key":"2024030117230329600_R25","first-page":"1462","article-title":"Pharmacologic effects of ketamine and its use in veterinary medicine","volume":"180","author":"Wright","year":"1982","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"2024030117230329600_R26","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2215-0366(22)00317-0","article-title":"Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability","volume":"9","author":"Smith-Apeldoorn","year":"2022","journal-title":"The Lancet Psychiatry"},{"key":"2024030117230329600_R27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1360-0443.2000.9545759.x","article-title":"Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later","volume":"95","author":"Curran","year":"2000","journal-title":"Addiction"},{"key":"2024030117230329600_R28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/dta.335","article-title":"Detecting ketamine in beverage residues: application in date rape detection","volume":"4","author":"Albright","year":"2012","journal-title":"Drug Testing and Analysis"},{"key":"2024030117230329600_R29","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4014","article-title":"A review of chromatographic methods for ketamine and its metabolites norketamine and dehydronorketamine","volume":"32","author":"Goktas","year":"2018","journal-title":"Biomedical Chromatography"},{"key":"2024030117230329600_R30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jat\/34.3.149","article-title":"A fast screening procedure for ketamine and metabolites in urine samples with tandem mass spectrometry","volume":"34","author":"Lin","year":"2010","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jat\/33.6.310","article-title":"Validation of an enzyme-linked immunosorbent assay screening method and a liquid chromatography-tandem mass spectrometry confirmation method for the identification and quantification of ketamine and norketamine in urine samples from Malaysia","volume":"33","author":"Harun","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R32","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jpba.2017.11.024","article-title":"Rapid and simple procedure for the determination of cathinones, amphetamine-like stimulants and other new psychoactive substances in blood and urine by GC-MS","volume":"149","author":"Mercieca","year":"2018","journal-title":"Journal of Pharmaceutical & Biomedical Analysis"},{"key":"2024030117230329600_R33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jat\/bks084","article-title":"Validation of LC-TOF-MS screening for drugs, metabolites, and collateral compounds in forensic toxicology specimens","volume":"37","author":"Guale","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R34","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.3390\/molecules20034915","article-title":"Understanding the physicochemical properties of mitragynine, a principal alkaloid of Mitragyna speciosa, for preclinical evaluation","volume":"20","author":"Ramanathan","year":"2015","journal-title":"Molecules"},{"key":"2024030117230329600_R35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00414-015-1279-y","article-title":"The pharmacology and toxicology of kratom: from traditional herb to drug of abuse","volume":"130","author":"Warner","year":"2016","journal-title":"International Journal of Legal Medicine"},{"key":"2024030117230329600_R36","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103817","article-title":"Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom","volume":"108","author":"Tobacyk","year":"2022","journal-title":"International Journal on Drug Policy"},{"key":"2024030117230329600_R37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2019.05.003","article-title":"Kratom policy: the challenge of balancing therapeutic potential with public safety","volume":"70","author":"Prozialeck","year":"2019","journal-title":"International Journal on Drug Policy"},{"key":"2024030117230329600_R38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuropharm.2017.08.026","article-title":"The medicinal chemistry and neuropharmacology of kratom: a preliminary discussion of a promising medicinal plant and analysis of its potential for abuse","volume":"134","author":"Kruegel","year":"2018","journal-title":"Neuropharmacology"},{"key":"2024030117230329600_R39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/02791072.2015.1096434","article-title":"Experiences of kratom users: a qualitative analysis","volume":"47","author":"Swogger","year":"2015","journal-title":"Journal of Psychoactive Drugs"},{"key":"2024030117230329600_R40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00216-010-4464-3","article-title":"Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology","volume":"400","author":"Philipp","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"2024030117230329600_R41","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jat\/bks073","article-title":"Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom","volume":"36","author":"Le","year":"2012","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.121971","article-title":"Identification of metabolites and potential biomarkers of kratom in urine","volume":"1140","author":"Basiliere","year":"2020","journal-title":"Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences"},{"key":"2024030117230329600_R43","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jat\/33.7.356","article-title":"Comprehensive analysis of drugs of abuse in urine using disposable pipette extraction","volume":"33","author":"Ellison","year":"2009","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R44","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11419-006-0006-2","article-title":"Direct detection of serum psilocin glucuronide by LC\/MS and LC\/MS\/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a \u201cmagic mushroom\u201d user","volume":"24","author":"Kamata","year":"2006","journal-title":"Forensic Toxicology"},{"key":"2024030117230329600_R45","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkz115","article-title":"ANSI\/ASB Standard 036 for method validation in forensic toxicology has replaced SWGTOX\u2019s version","volume":"44","author":"LeBeau","year":"2020","journal-title":"Journal of Analytical Toxicology"},{"key":"2024030117230329600_R46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0731-7085(02)00278-9","article-title":"Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man","volume":"30","author":"Hasler","year":"2002","journal-title":"Journal of Pharmaceutical & Biomedical Analysis"},{"key":"2024030117230329600_R47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jat\/bkz064","article-title":"The trouble with kratom: analytical and interpretative issues involving mitragynine","volume":"43","author":"Papsun","year":"2019","journal-title":"Journal of Analytical Toxicology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkae002\/56616189\/bkae002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/48\/2\/111\/56813749\/bkae002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/48\/2\/111\/56813749\/bkae002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T12:23:49Z","timestamp":1709295829000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/48\/2\/111\/7591598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,27]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkae002","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2024,1,27]]}}}